Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.370.360.340.320.33

What is the latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of LINCOLN PHARMACEUTICALS is 0.37 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.37
Mar20240.36
Mar20230.34
Mar20220.32
Mar20210.33

How is Fixed Capital/Sales of LINCOLN PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.37
2.78
Mar2024 0.36
5.88
Mar2023 0.34
6.25
Mar2022 0.32
-3.03
Mar2021 0.33 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,218.7 Cr 6.5% -1.8% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

6.5%

-1.8%

8.3%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses